FluoxetineLack of efficacy following off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1939卷 / 1期

关键词：

D O I：

10.1007/s40278-023-31627-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：219 / 219

相关论文

共 50 条

[1] DexamethasoneLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2023, 1967 (1) : 143 - 143
[2] AntibacterialsLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2022, 1920 (1) : 43 - 43
[3] EculizumabLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2021, 1862 (1) : 196 - 196
[4] DexamethasoneLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2022, 1887 (1) : 259 - 259
[5] AmiodaroneLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2023, 1969 (1) : 29 - 29
[6] FavipiravirLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2023, 1945 (1) : 254 - 254
[7] RituximabLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2022, 1905 (1) : 444 - 444
[8] MethylprednisoloneLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2022, 1902 (1) : 280 - 280
[9] HydroxychloroquineLack of efficacy following an off-label use: case report
[J]. Reactions Weekly, 2021, 1858 (1) : 182 - 182
[10] VedolizumabLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2023, 1938 (1) : 1250 - 1250

← 1 2 3 4 5 →